【24h】

Colonic targeting of the polypeptide drug nisin

机译:结肠靶向多肽药物NISIN

获取原文
获取外文期刊封面目录资料

摘要

Nisin is a peptide antimicrobial agent. It was found to be active against Clostridium difficile which causes severe repulsing diarrhea, and vancomycin resistant enterococci, which causes a large increase in the number of untreatable or difficult to treat bacterial infections. Both organisms colonize in the colon. Therefore, nisin must be formulated in a dosage form which immediately releases the intact antimicrobial agent in the colon. Nisin being a polypeptide is digested by the proteolytic enzymes in the small intestine. Therefore, protection of nisin through the gastrointestinal tract until it reaches the colon is essential. Developing colonic drug delivery system, using currently available materials, with potential to succeed should be based on utilization of pH and transit time of the different segments of the GIT. In this study EUDRAGIT L30D coating was used to target nisin to the colon.
机译:Nisin是一种肽抗微生物剂。发现它是对梭菌艰难梭菌的活性,导致严重的痉挛性腹泻,并且万霉素抗性肠球菌,这导致未经治疗或难以治疗细菌感染的数量大幅增加。两种生物都在结肠中殖民。因此,NISIN必须以剂量形式配制,其立即释放结肠中的完整抗微生物剂。在小肠中的蛋白水解酶消化乳白质是多肽。因此,通过胃肠道保护Nisin直到它到达结肠是必不可少的。使用目前可用的材料开发结肠药物递送系统,潜在的旨在成功应基于用于Git的不同段的pH和运输时间的利用。在本研究中,Eudragit L30D涂层用于靶向结肠。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号